The Israel Institute for Biological Research announced the start of phase two in human clinical trials for their coronavirus vaccine on Monday.
The trials will begin within the next few days with over 1,000 volunteers over the age of 18, and will initiate at Sheba Medical Center, Tel Hashomer and Hadassah. It will later expand to other medical centers throughout the country. The first phase of the vaccine was a success, reporting no serious side effects, which led to its approval by the health ministry. It was also recommended by two committees of experts.
Phase two trials are expected to last at least a few months.
If successful, the vaccine trials could advance to phase three, testing the vaccine on 30,000 volunteers.
This is a developing story, please check back for updates.